← Back to Clinical Trials
Recruiting NCT07095062

NCT07095062 Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07095062
Status Recruiting
Phase
Sponsor IRCCS Eugenio Medea
Condition Friedreich's Ataxia
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-07-07
Primary Completion 2026-12-31

Trial Parameters

Condition Friedreich's Ataxia
Sponsor IRCCS Eugenio Medea
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 8 Years
Max Age 60 Years
Start Date 2025-07-07
Completion 2026-12-31
Interventions
HD-EEG recordings, combined with cognitive and motor assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Prospective, exploratory, multicenter pilot study investigating the structural and functional connectome in patients with Friedreich's Ataxia (FRDA) using high-density electroencephalogram (HD-EEG). The aim is to identify neurophysiological biomarkers and analyze the relationship between cortical connectivity, cognitive functioning, and clinical severity, particularly in response to rehabilitation treatment.

Eligibility Criteria

Inclusion criteria: * age between 8 and 60 years; * genetic diagnosis of FRDA: presence of guanine-adenine trinucleotide (GAA) expansion in the two alleles of the fratassin gene, GAA1 and GAA2; * score on the Scale for the Assessment and Rating of Ataxia (SARA) \< 30; * ability to take part in a neuropsychological assessment in Italian. Exclusion criteria: * age different from the range 8-60 years; * diagnosis of acquired ataxia or other genetic ataxias; * SARA scale score ≥ 30; * inability to take part in an Italian-language neuropsychological assessment

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology